Pump jacks at an oil well and fracking site in California's San Joaquin Valley. Photo: Citizens of the Planet / Education Images / UIG via Getty Images

The U.S. is set to surpass Saudi Arabia — and possibly Russia — as an oil producer this year, and has set new records for total fossil fuel production. Yet the U.S. is losing ground in the race to dominate fast-growing advanced energy markets, particularly in light of the White House's decision to impose 30% tariffs on solar panel imports — grabbing a larger slice of a shrinking pie through trade barriers while other countries capture new opportunities.

Saudi Arabia, for example, intends to invest $7 billion in renewable projects this year, while a Saudi industrial group is already developing 5 gigawatts of renewable projects globally, with a major focus on Latin America. Another Saudi-Chinese consortium is investing significant sums in Egypt's nascent renewable energy sector.

China is set to account for more than half of global solar deployment and electric vehicle sales this year. Beijing's "Belt and Road" initiative will accelerate the Middle Kingdom's plans to become a clean energy powerhouse, and China is also poised to construct a network of high-voltage power lines across the Eurasian landmass. Add to this the fact that the U.S. will soon fall behind China in overall R&D spending, and the picture of an energy-rich, yet complacent, America emerges.

In offshore wind power, the U.S. currently produces around 30 megawatts, while Denmark — with roughly 1/60 the population and GDP — boasts 1,300 megawatts.

Why it matters: Missing domestic opportunities is one thing — after all, the U.S. is not a fast-growing energy market — but losing the advanced energy race will diminish American influence and competitiveness abroad as the future of energy takes shape.

David Livingston is the deputy director of Climate and Advanced Energy at the Atlantic Council.

Go deeper

1 hour ago - Health

The top-selling drugs in the U.S. in 2019

Data: IQVIA, company financial documents; Chart: Andrew Witherspoon/Axios

The 10 highest-selling drugs in the U.S. last year gave away more than $23 billion in rebates to insurance intermediaries, but still netted almost $58 billion in sales.

The big picture: The U.S. drug pricing system is filled with confusing numbers, and many entities profit off the flow of drugs, but pharmaceutical companies retain a vast majority of the proceeds.

Caitlin Owens, author of Vitals
2 hours ago - Health

America's flying blind on its coronavirus response

Illustration: Aïda Amer/Axios

A month after the Trump administration changed how hospital data is reported, the public release of this data "has slowed to a crawl," the Wall Street Journal reports.

The big picture: This is the latest example of how the world's wealthiest country just can't get it together.

Updated 2 hours ago - World

Pandemic plunges U.K. into "largest recession on record"

The scene near the Royal Exchange and the Bank of England in the City of London, England. Photo: Tolga Akmen/AFP via Getty Images

The United Kingdom slumped into recession as its gross domestic product GDP shrank 20.4% compared with the first three months of the year, the Office of National Statistics (ONS) confirmed Wednesday.

Why it matters: Per an ONS statement, "It is clear that the U.K. is in the largest recession on record." The U.K. has faired worse than any other major European economy from coronavirus lockdowns, Bloomberg notes. And finance minister Rishi Sunak warns the situation is likely to worsen.